LARIMAR THERAPEUTICS
Live / Registered — Registered (as of 26 Mar 2024)
What this means for you
Registered since 26 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90059153
- Registration number
- 7340237
- Mark type
- Design + words
- Filed
- 17 Jul 2020
- Published for opposition
- 05 Jan 2021
- Registered
- 26 Mar 2024
- Attorney of record
- Keith Toms, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases
Owner
- LARIMAR THERAPEUTICS, INC., BALA CYNWYD, PA, US
- LARIMAR THERAPEUTICS, INC., BALA CYNWYD, PA, US
- Chondrial Therapeutics, Inc., Bala Cynwyd, PA, US
- Chondrial Therapeutics, Inc., Bala Cynwyd, PA, US
Prosecution history
- 26 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jan 2024 — USE AMENDMENT FILED
- 18 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 06 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2023 — SOU EXTENSION 5 GRANTED
- 01 Sept 2023 — SOU EXTENSION 5 FILED
- 01 Sept 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2023 — SOU EXTENSION 4 GRANTED
- 28 Feb 2023 — SOU EXTENSION 4 FILED
- 13 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL